Synthesis of biotinylated photoaffinity probes based on arylsulfonamide γ-secretase inhibitors
暂无分享,去创建一个
Yasuko Takahashi | Takeshi Iwatsubo | Tohru Fukuyama | T. Iwatsubo | T. Kan | T. Tomita | T. Fukuyama | S. Yokoshima | Toshiyuki Kan | Satoshi Yokoshima | Taisuke Tomita | Yasuko Takahashi | Haruhiko Fuwa | Kenichi Hiromoto | Hideaki Natsugari | H. Fuwa | H. Natsugari | Kenichi Hiromoto
[1] Y. Tohda,et al. A convenient synthesis of acetylenes: catalytic substitutions of acetylenic hydrogen with bromoalkenes, iodoarenes and bromopyridines , 1975 .
[2] T. Iwatsubo,et al. The role of presenilin cofactors in the γ-secretase complex , 2003, Nature.
[3] Maurice Goeldner,et al. Recent Trends in Photoaffinity Labeling , 1995 .
[4] J. Treanor,et al. Fenchylamine sulfonamide inhibitors of amyloid beta peptide production by the gamma-secretase proteolytic pathway: potential small-molecule therapeutic agents for the treatment of Alzheimer's disease. , 2000, Journal of medicinal chemistry.
[5] L. Tarassishin,et al. Stereoselective Synthesis of Photoreactive Peptidomimetic γ-Secretase Inhibitors , 2004 .
[6] David W. Smith,et al. Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor , 2005, Journal of Pharmacology and Experimental Therapeutics.
[7] C. Haass,et al. A γ‐secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish , 2002, EMBO reports.
[8] Jay S. Fine,et al. Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation* , 2004, Journal of Biological Chemistry.
[9] Min Xu,et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1 , 2000, Nature.
[10] P. Knochel,et al. Functionalized magnesium organometallics as versatile intermediates for the synthesis of polyfunctional heterocycles. , 2006, Chemical communications.
[11] T. Iwatsubo,et al. Highly efficient synthesis of medium-sized lactams via intramolecular Staudinger–aza-Wittig reaction of ω-azido pentafluorophenyl ester: synthesis and biological evaluation of LY411575 analogues , 2004 .
[12] Gregory D. Longmore,et al. γ-Secretase inhibitors repress thymocyte development , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] D. Selkoe,et al. Defining molecular targets to prevent Alzheimer disease. , 2005, Archives of neurology.
[14] T. Iwatsubo,et al. Parallel synthesis of DAPT derivatives and their γ-secretase-inhibitory activity , 2004 .
[15] Leonid Tarassishin,et al. Processing of Notch and amyloid precursor protein by γ-secretase is spatially distinct , 2004 .
[16] S. Horwitz,et al. Design, synthesis, and biological evaluation of potent discodermolide fluorescent and photoaffinity molecular probes. , 2005, Organic letters.
[17] T. Iwatsubo,et al. Solid-phase synthesis of photoaffinity probes: highly efficient incorporation of biotin-tag and cross-linking groups. , 2003, Chemical communications.
[18] W. H. Jordan,et al. Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional γ-Secretase Inhibitor* , 2003, Journal of Biological Chemistry.
[19] B. Schmidt. Aspartic Proteases Involved in Alzheimer's Disease , 2003, Chembiochem : a European journal of chemical biology.
[20] Raphael Kopan,et al. γ-Secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney , 2003, Development.
[21] N. Perrimon,et al. γ‐Secretase/presenilin inhibitors for Alzheimer's disease phenocopy Notch mutations in Drosophila , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] Naoyuki Sugiyama,et al. Development of Biotin–Avidin Technology to Investigate Okadaic Acid-Promoted Cell Signaling Pathway , 2000 .
[23] K. Sonogashira,et al. Development of Pd–Cu catalyzed cross-coupling of terminal acetylenes with sp2-carbon halides , 2002 .
[24] N. Krause,et al. Improved Procedures for the Palladium-Catalyzed Coupling of Terminal Alkynes with Aryl Bromides (Sonogashira Coupling)† , 1998 .
[25] Francois Pognan,et al. Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[26] M. Wolfe,et al. The initial substrate-binding site of γ-secretase is located on presenilin near the active site , 2005 .
[27] J. Best,et al. A novel series of potent γ-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core , 2005 .
[28] G. Prestwich,et al. Benzophenone photophores in biochemistry. , 1994, Biochemistry.
[29] G. Prestwich,et al. Using photolabile ligands in drug discovery and development. , 2000, Trends in biotechnology.
[30] T. Iwatsubo,et al. C-terminal Fragment of Presenilin Is the Molecular Target of a Dipeptidic γ-Secretase-specific Inhibitor DAPT (N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-Butyl Ester)* , 2006, Journal of Biological Chemistry.
[31] T. Iwatsubo,et al. Sulindac Sulfide Is a Noncompetitive γ-Secretase Inhibitor That Preferentially Reduces Aβ42 Generation* , 2003, The Journal of Biological Chemistry.
[32] S. Wagner,et al. Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897 , 2005 .
[33] O. Mitsunobu. The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products , 1981 .
[34] R. Perlmutter,et al. Presenilin-dependent γ-secretase activity modulates thymocyte development , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] T. Iwatsubo,et al. gamma-secretase as a therapeutic target for treatment of Alzheimer's disease. , 2006, Current pharmaceutical design.